Revolutionary weight loss drug Wegovy and anti-diabetes medication Ozempic may be linked to a rare eye disorder, according to a new study published Wednesday. 

Researchers from Massachusetts General Hospital found that patients prescribed either Ozempic or Wegovy had an elevated risk of developing nonarteritic anterior ischemic optic neuropathy, or NAION.